Janssen Search
Search results
Sustainability – Green Chemistry
Product Stewardship Through the Lifecycle: Green Chemistry and Technology Yield Business and Environmental Benefits At Janssen, our purpose is to help people lead healthier, happier lives. To create a healthier future, we see an opportunity to create ...
Chronic Infections
Article Type: Infectious Diseases & Vaccines Chronic Infections HIV The global HIV epidemic began more than 40 years ago. There's been significant progress in tackling this virus since then, but HIV remains one of the most significant ...
Our Work
Article Type: Human Microbiome Institute Our Work We work with our partners to translate exciting ideas into therapies and other health solutions, and to create knowledge and resources that will advance the field as a whole. Our current collaborations ...
Science of Immorbidity
2 nd International Symposium, 12 October 2017: The Science of Immorbidity- New Approaches to Prevention in Creating a World Without Disease About the Symposium The word immorbidity describes a state where a person is able to evade the diseases that ...
Our Commitment to Climate Action
Our Commitment to Climate Action With our reach, expertise and convening power, we are taking action to positively impact planetary health and support the resilience of our business for generations to come. Johnson & Johnson has been setting and ...
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development
Neurodegenerative Disorders: Utilizing biomarker sciences to drive disease understanding, patient identification, and accelerated development We are in the midst of a scientific renaissance in neurodegeneration, driven by growing evidence of overarching ...
Research & Development
R&D Focus Areas The R&D Leadership Team Transparency of Clinical Trial Data Clinical Trials Careers in Research & Development Cracking the Genetic Code Artificial Intelligence Our Approach to R&D Janssen Storytellers: The Journey Forward ...
Infectious Disease Treatment Development
Development Article Type: Infectious Diseases & Vaccines Exploring the potential of multiple treatment combinations to make a difference in patients' lives The Janssen Infectious Diseases & Vaccines multidisciplinary development team, ...
Neil Davie, Ph.D.
NEIL DAVIE, Ph.D. HEAD, LATE DEVELOPMENT CARDIOVASCULAR, METABOLISM & PULMONARY HYPERTENSION Neil Davie, Ph.D. is the Head, Late Development, of Cardiovascular, Metabolism, & Pulmonary Hypertension (CVM & PH). He has extensive experience as a ...
Suzanne (Sue) McMonigle
SUZANNE (SUE) MCMONIGLE SENIOR DIRECTOR COMMERCIAL LEADER WORLD WITHOUT DISEASE ACCELERATOR As Senior Director, Commercial Leader for the World Without Disease Accelerator (WWDA), Sue partners with Johnson & Johnson (J&J) Commercial teams across ...